Thank you for reading! We hope that you continue to enjoy our free content.
Welcome! We hope that you enjoy our free content.
Thank you for signing in! We hope that you continue to enjoy our free content.
Please log in, or sign up for a new account and purchase a subscription to continue reading.
Please purchase a subscription to continue reading.
Your current subscription does not provide access to this content.
Convenient Home Delivery of Sweetwater Reporter PLUS Unlimited Digital Access to articles on sweetwaterreporter.com, and E-Edition access.
|Home Delivery (Sweetwater and Roscoe) 3 Months||$29.00||for 90 days|
|Home Delivery (Sweetwater and Roscoe) 6 Months||$56.00||for 180 days|
|Home Delivery (Sweetwater and Roscoe) 12 Months||$100.00||for 365 days|
|Mail Delivery (Nolan County) 3 Months||$33.00||for 90 days|
|Mail Delivery (Nolan County) 6 Months||$64.00||for 180 days|
|Mail Delivery (Nolan County) 12 Months||$125.00||for 365 days|
|Mail Delivery (Outside Nolan County) 3 Months||$38.00||for 90 days|
|Mail Delivery (Outside Nolan County) 6 Months||$74.00||for 180 days|
|Mail Delivery (Outside Nolan County) 12 Months||$135.00||for 365 days|
E-Edition access AND unlimited digital access to articles on sweetwaterreporter.com
|1 Day||$0.99||for 1 day|
|1 Month||$7.00||for 30 days|
|3 Months||$21.00||for 90 days|
|6 Months||$40.00||for 180 days|
|12 Months||$77.00||for 365 days|
AbbVie (NY: ABBV )
153.93 +0.13 (+0.08%) Official Closing Price Updated: 7:00 PM EDT, Jul 5, 2022 Add to My Watchlist
All News about AbbVie
6 Best Dividend Stocks of All Time
June 21, 2022
When you're ready to say, "Tag, you're it!" and let dividend stocks take over your portfolio, you naturally want to gravitate toward A+ companies. Luckily, you don't need to look much further than...
Exposures Interest Rates
AbbVie Signs Licensing Deal With Sirona Biochem For Effective New Hydroquinone Alternative
June 15, 2022
AbbVie acquires the rights to market and commercialize Sirona’s breakthrough TFC-1067 compound AbbVie agrees to upfront, milestone, and royalty payments for patented molecules Sirona’s TFC-1067 is...
Topics Intellectual Property
Exposures Intellectual Property
Via AB Newswire
ABBV FINAL DEADLINE MONDAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important June 6 Deadline in Securities Class Action - ABBV
June 04, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.